The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Balan V.E.

Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Tikhomirova E.V.

Moscow Regional Research Institute of Obstetrics and Gynecology

Zaidieva Ya.Z.

Moscow Regional Research Institute of Obstetrics and Gynecology

Kruchinina E.V.

Moscow Regional Research Institute of Obstetrics and Gynecology

Zhuravel’ A.S.

Moscow Regional Research Institute of Obstetrics and Gynecology

Titchenko Yu.P.

Moscow Regional Research Institute of Obstetrics and Gynecology

Fomina-Nilova O.S.

Moscow Regional Research Institute of Obstetrics and Gynecology

Tsar’kova A.V.

Moscow Regional Research Institute of Obstetrics and Gynecology

The changing shape of menopausal hormone therapy

Authors:

Balan V.E., Tikhomirova E.V., Zaidieva Ya.Z., Kruchinina E.V., Zhuravel’ A.S., Titchenko Yu.P., Fomina-Nilova O.S., Tsar’kova A.V.

More about the authors

Journal: Russian Bulletin of Obstetrician-Gynecologist. 2020;20(4): 95‑99

DOI: 10.17116/rosakush20202004195

Views: 1380

Downloaded: 26

Download PDF (RU)
Contact the author
Table of contents

THE CHANGING SHAPE OF MENOPAUSAL HORMONE THERAPY
THE CHANGING SHAPE OF MENOPAUSAL HORMONE THERAPY

To cite this article:

Balan VE, Tikhomirova EV, Zaidieva YaZ, et al. . The changing shape of menopausal hormone therapy. Russian Bulletin of Obstetrician-Gynecologist. 2020;20(4):95‑99. (In Russ.)
https://doi.org/10.17116/rosakush20202004195

Подписка 2025-2 (Russian Bulletin of Obstetrician-Gynecologist)
 
МСФ на ЯМ
Close metadata
Recommended articles:
Analysis of quality of the women with meno­pause mana­gement on the example of women’s health clinic in Moscow. Russian Journal of Preventive Medi­cine. 2024;(4):25-31
Features of the clinical picture of affe­ctive diso­rders in women during the meno­pausal transition and early postmenopause. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):75-79
Pathophysiological mechanisms of vascular wall alte­rations in meno­pausal women. Russian Journal of Preventive Medi­cine. 2024;(6):91-97
Carbonyl stress in meno­pausal women with inso­mnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):192-197
Awareness of women about the prevention and correction of climacteric diso­rders. Russian Journal of Preventive Medi­cine. 2025;(1):57-62

The article presents the results of recent studies on the effectiveness, safety and duration of menopausal hormone therapy. Presented modern data on the indications and benefits of low and ultra-low doses of menopausal hormone therapy.

Keywords:

menopausal hormone therapy
low and ultra-low doses of estrogens
menopause
menopausal hormone therapy
low and ultra-low doses of estrogens
menopause

Authors:

Balan V.E.

Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Tikhomirova E.V.

Moscow Regional Research Institute of Obstetrics and Gynecology

Zaidieva Ya.Z.

Moscow Regional Research Institute of Obstetrics and Gynecology

Kruchinina E.V.

Moscow Regional Research Institute of Obstetrics and Gynecology

Zhuravel’ A.S.

Moscow Regional Research Institute of Obstetrics and Gynecology

Titchenko Yu.P.

Moscow Regional Research Institute of Obstetrics and Gynecology

Fomina-Nilova O.S.

Moscow Regional Research Institute of Obstetrics and Gynecology

Tsar’kova A.V.

Moscow Regional Research Institute of Obstetrics and Gynecology

Received:

21.03.2020

Accepted:

17.04.2020

List of references:

  1. Smetnik VP. From the chief editor. Menopause. 2011;2:3-53. (In Russ.).
  2. Smetnik VP, Balan VE, Zaydieva YZ, Maychuk EYu, Mychka VB. Management of women with cardiovascular risk in peri- and postmenopausal women. Rossiiskii kardiologicheskii zhurnal. 2008;4:40-57. (In Russ.).
  3. The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause. 2012;19:257-271. 
  4. World population projected to reach 9.6 billion by 2050 with most growth in developing regions, especially Africa — say 21 June 2017, New York. https://www.un.org/development/desa/en/news/population/world-population-prospects-2017.html
  5. Nachtigall LE, Nachtigall MJ. The perimenopause and vasomotor symptoms. Posgraduate Medicine, A special report. P. 5-7.  https://doi.org/10.1016/S1086-5802(16)31127-5
  6. Raus K. Conference Proceedings «Pres 2011 — Gynecology and Urology. Phytoneering research and experience summit». Mallorca. 2011. https://www.researchgate.net/topic/Phytotherapy/publications
  7. The North American Menopause Society. The 2012 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2012;19:257. 
  8. Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, Gold EB, Hess R, Joffe H, Kravitz HM, Tepper PG, Thurston RC. The Study of Women’s Health Across the Nation (SWAN). Duration of menopausal vasomotor symptoms over the menopause transition [published online ahead of print February 16, 2015].
  9. Gartoulla P, Worsley R, Bell RJ, Davis SR. Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years [published online ahead of print February 20, 2015]. Menopause. 2015;22:7:694-701.  https://doi.org/10.1097/gme.0000000000000383
  10. Kaunitz AM, Manson JE. EDITORIAL. Failure to treat menopausal symptoms: a disconnect between clinical practice and scientific data. Menopause. 2015;22:7: https://doi.org/10.1097/gme.0000000000000457
  11. Schneider HPG. The view of the International Menopause Society on The WHI. Climacteric. 2002;5:3:211-216. 
  12. Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ, Wactawski-Wende J, Jackson RD, Limacher M, Margolis KL, Wassertheil-Smoller S, Beresford SA, Cauley JA, Eaton CB, Gass M, Hsia J, Johnson KC, Kooperberg C, Kuller LH, Lewis CE, Liu S, Martin LW, Ockene JK, O’Sullivan MJ, Powell LH, Simon MS, Van Horn L, Vitolins MZ, Wallace RB. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA. 2013;310:1353-1368.
  13. Stefanick ML. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative Randomized Trials. JAMA. 2013; 310:1353-1368.
  14. Kaunitz AM. Hormone therapy and breast cancer risk: trumping fear with facts. Menopause. 2006;13:160-163. 
  15. Smith GC, Wood AM, White IR, Pell JP, Hattie J. Birth weight and the risk of cardiovascular disease in the maternal grandparents. Am J Epidemiol. 2010;171:736-744. 
  16. de Villiers TJ, Pines A, Panay N, Gambacciani M, Archer DF, Baber RJ, Davis SR, Gompel AA, Henderson VW, Langer R, Lobo RA, Plu-Bureau G, Sturdee, DW. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric. 2013;16:316-337. 
  17. de Villiers TJ, Gass ML, Haines CJ, Hall JE, Lobo RA, Pierroz DD, Rees, M. Global Consensus Statement on Menopausal Hormone Therapy. Climacteric. 2013;16:203-204. 
  18. ACOG Practice Bulletin No. 141: Management of Menopausal Symptoms. Obstet Gynecol. 2014;123:202-216. 
  19. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial et al. JAMA. 2002;288:321-333. 
  20. Ettinger B, Wang SM, Leslie RS, Patel BV, Boulware MJ, Mann ME, McBride M. Evolution of postmenopausal hormone therapy between 2002 and 2009. Menopause. 2012;19:6:610-615. 

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.